BOSTON DR LIM

부러우면 지는거다 (36) Stanley T. Crooke, MD, PhD

March 20, 2024March 20, 2024

BIOTECH (145) Crinetics Pharmaceuticals: Specialty Endocrine Disorders

March 19, 2024March 20, 2024

BIOTECH (144) Carmot Therapeutics: Chemotype Evolution (CE) Platform to Lead to Lumakras (Sotorasib, AMG510) KRAS G12C Inhibitor

March 19, 2024March 19, 2024

BIOTECH (143) EvolveImmune Therapeutics: Multifunctional T-Cell Engager Platform

March 18, 2024March 18, 2024

BIOTECH (142) Shinobi Therapeutics: Allogeneic CD8αβ iPS-T Cell Platform

March 18, 2024March 18, 2024

BIOTECH (141) Moonwalk Biosciences: Epigenome Editing with AI/ML for Methylome

March 18, 2024March 18, 2024

BIOTECH (140) Tr1X: T Regulatory Type 1 (Tr1) Cell Therapy for Autoimmune Disease

March 18, 2024March 18, 2024

BIOTECH (139) Nxera Pharma (former Sosei Heptares): mini-G proteins (GPCR) & StaR (Stabilized Receptor) Platform

March 18, 2024March 18, 2024

노잼투자 (10) Verizon (VZ)

March 18, 2024

부러우면 지는거다 (35) European Dividend Growth Investor

March 17, 2024March 18, 2024